Expertise in
3
conditions

Dr. Katherine J. Willingham

Internal Medicine
Cotton O'Neil Clinic Revocable Trust
901 SW Garfield Ave, 
Topeka, KS 
Accepting New Patients
Offers Telehealth
Expertise in
3
conditions
Cotton O'Neil Clinic Revocable Trust
901 SW Garfield Ave, 
Topeka, KS 

Overview

Katherine Willingham is a primary care provider, practicing in Internal Medicine in Topeka, Kansas.

Dr. Willingham is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Rhizomelic Pseudopolyarthritis, Polymyalgia Rheumatica, and Sciatica.

She is actively involved in clinical research, participating in 7 clinical trials. Dr. Willingham is currently accepting new patients.

Specialties

Internal Medicine

Licenses

Internal Medicine in KS

Hospital Affiliations

University Of Kansas Health System - St Francis Campus
University Of Kansas Hospital
Stormont Vail Hospital

Languages Spoken

English
French

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Freedom Life
  • INSURANCE PLAN
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Sunflower Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Cotton O'Neil Clinic Revocable Trust
901 SW Garfield Ave, Topeka, KS 66606
Other Locations
Stormont Vail Hospital
1500 SW 10th Ave, Topeka, KS 66604

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Assessment of Safety, Tolerability and Efficacy of LY3002813 in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability and Efficacy of LY3002813 in Early Symptomatic Alzheimer's Disease
Enrollment Status: Completed
Publish Date: March 19, 2026
Intervention Type: Drug
Study Drug: LY3002813
Study Phase: Phase 2
Efficacy and Safety of Tirzepatide Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight- Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-1)
Efficacy and Safety of Tirzepatide Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight- Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-1)
Enrollment Status: Completed
Publish Date: July 24, 2025
Intervention Type: Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
Donanemab Follow-On Study: Safety, Tolerability, And Efficacy in Symptomatic Alzheimer's Disease With Validation of Remote Neuropsychological Assessments
Donanemab Follow-On Study: Safety, Tolerability, And Efficacy in Symptomatic Alzheimer's Disease With Validation of Remote Neuropsychological Assessments
Enrollment Status: Completed
Publish Date: June 13, 2025
Intervention Type: Drug, Other
Study Drug: Donanemab
Study Phase: Phase 2
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo After an Intensive Lifestyle Program in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double Blind, Placebo-Controlled Trial (SURMOUNT-3)
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo After an Intensive Lifestyle Program in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double Blind, Placebo-Controlled Trial (SURMOUNT-3)
Enrollment Status: Completed
Publish Date: May 16, 2024
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
A Randomized, Double-blind, Placebo-Controlled Trial Comparing the Efficacy and Safety of Three Tirzepatide Doses Versus Placebo in Patients With Type 2 Diabetes, Inadequately Controlled With Diet and Exercise Alone
A Randomized, Double-blind, Placebo-Controlled Trial Comparing the Efficacy and Safety of Three Tirzepatide Doses Versus Placebo in Patients With Type 2 Diabetes, Inadequately Controlled With Diet and Exercise Alone
Enrollment Status: Completed
Publish Date: October 20, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials
Similar Doctors
Expertise in
33
conditions
Dr. Kevin R. Sundbye
Internal Medicine
Expertise in
33
conditions
Dr. Kevin R. Sundbye
Internal Medicine

Stormont Vail Hospital

1500 SW 10th Ave, 
Topeka, KS 
 (0.1 miles away)
785-354-5225
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Kevin Sundbye is a primary care provider, practicing in Internal Medicine in Topeka, Kansas. Dr. Sundbye is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Heart Failure with Preserved Ejection Fraction (HFpEF), Idiopathic Edema, Alzheimer's Disease, and COVID-19. Dr. Sundbye is currently accepting new patients.

Expertise in
43
conditions
Dr. Dushyant S. Dahiya
Internal Medicine
Expertise in
43
conditions
Dr. Dushyant S. Dahiya
Internal Medicine

Office

3901 Rainbow Blvd # 102, 
Kansas City, KS 
 (57.6 miles away)
913-588-6019
Languages Spoken:
English
See accepted insurances

Dushyant Dahiya is a primary care provider, practicing in Internal Medicine in Kansas City, Kansas. Dr. Dahiya is highly rated in 43 conditions, according to our data. His clinical expertise encompasses Hereditary Pancreatitis, Gastrointestinal Bleeding, Acute Pancreatitis, Endoscopy, and Colonoscopy.

Expertise in
13
conditions
Dr. Kevin L. Bernd
Internal Medicine
Expertise in
13
conditions
Dr. Kevin L. Bernd
Internal Medicine

Stormont Vail Hospital

1500 SW 10th Ave, 
Topeka, KS 
 (0.1 miles away)
785-354-6000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Kevin Bernd is a primary care provider, practicing in Internal Medicine in Topeka, Kansas. Dr. Bernd is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Attack, Coronary Heart Disease, and Atherosclerosis. Dr. Bernd is currently accepting new patients.

Frequently Asked Questions about Dr. Katherine J. Willingham

How do I make an appointment with Dr. Katherine J. Willingham?

You can book an appointment with Dr. Katherine J. Willingham by calling their office at 785-354-9591. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Katherine J. Willingham a top-rated expert for Large-Cell Immunoblastic Lymphoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Katherine J. Willingham is classified as an Advanced expert for Large-Cell Immunoblastic Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Katherine J. Willingham specialize in?

While Dr. Katherine J. Willingham is a Internal Medicine, they have specific expertise in Large-Cell Immunoblastic Lymphoma, Rhizomelic Pseudopolyarthritis, and Polymyalgia Rheumatica. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Katherine J. Willingham accept my insurance?

Dr. Katherine J. Willingham accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 785-354-9591 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Willingham's expertise for a condition
ConditionClose
      View All 127 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile